Academic Faculty from University of Tehran, Iran
Dr. Hossein Aminianfar is a dedicated academic and veterinary anatomic pathologist with a strong reputation in translational research, toxicologic pathology, and regenerative medicine. With a combination of scholarly excellence and applied diagnostic expertise, he brings a multidimensional perspective to the field of veterinary science. Currently serving as an Assistant Professor at the University of Tehran’s Faculty of Veterinary Medicine, he is also the founder and CEO of ArenaPath, a specialized service for comparative pathology in Tehran. His extensive publication record in internationally indexed journals, covering a range of topics from stem cell therapies to vaccine safety and biomaterials, underscores his commitment to impactful, cross-disciplinary research. Dr. Aminianfar is recognized for his diagnostic proficiency in veterinary pathology, particularly in equine, ruminant, and forensic cases. His affiliations with leading professional societies, including the American Society of Toxicology Pathology, reinforce his active engagement with the global scientific community. He has also earned multiple certifications and contributed to high-profile research studies in both academic and clinical contexts. His passion for advancing veterinary diagnostics and bridging the gap between laboratory findings and clinical application make him a significant contributor to his field and a strong contender for prestigious research awards.
Professional Profile
Education
Dr. Hossein Aminianfar holds an impressive academic background rooted in veterinary medicine and pathology. He earned his Doctor of Veterinary Medicine (DVM) degree in 2012 from the University of Tehran, Iran, laying the foundation for his specialized career. Continuing his academic pursuit, he completed his Doctorate in Veterinary Anatomic Pathology (DVSc) from the same institution in 2017. His DVM dissertation, titled “Preparation and assessment of histological, biochemical, and biomechanical properties of extracellular matrix produced from the host tissue response against subcutaneously-implanted dextran hydrogel in rats,” was recognized internationally and presented at the 2nd Joint European Congress of the ESVP, ESTP, and ECVP in Berlin. His doctoral thesis, “Osteogenic differentiation of mesenchymal stem cells by osteoblast-imprinted substrate,” demonstrated his expertise in regenerative medicine and cellular pathology. This academic journey highlights his deep engagement with experimental research and translational science. Dr. Aminianfar’s formal education reflects not only his technical skill but also his ability to address complex scientific questions, paving the way for innovative applications in both veterinary and human biomedical sciences. His strong educational foundation has been instrumental in shaping his career in academia and in the development of advanced diagnostic and therapeutic techniques.
Professional Experience
Dr. Hossein Aminianfar brings a wealth of experience in both academic and professional domains of veterinary pathology. He currently serves as an Assistant Professor in the Department of Pathology at the Faculty of Veterinary Medicine, University of Tehran, a role he has held since 2022. His responsibilities include teaching, supervising student research, and leading cutting-edge investigations in toxicologic and comparative pathology. In 2021, he founded ArenaPath, a comparative pathology service based in Tehran, where he functions as both Founder and CEO. This venture provides diagnostic services and fosters collaboration between research institutions and veterinary clinics. In addition to academia and entrepreneurship, Dr. Aminianfar has substantial experience in veterinary diagnostics, particularly in diagnosing ruminant abortions, placenta pathology, equine disorders, and forensic pathology. His role on the pathology committee of the Iranian Veterinary Society and his membership in the Research Council of the Urology Research Center at Tehran University of Medical Sciences underscore his interdisciplinary influence. He also holds memberships in several respected scientific organizations, such as the American Society of Toxicology Pathology and the Institute of Biomedical Research. Collectively, his professional trajectory reflects a blend of research innovation, practical diagnostic application, and educational leadership in the field.
Research Interests
Dr. Aminianfar’s research interests lie at the intersection of veterinary pathology, regenerative medicine, and translational biomedical sciences. He is particularly focused on toxicologic pathology and the pre-clinical evaluation of pharmaceuticals in animal models. His work in this area contributes to the safety and efficacy testing of novel drug compounds, bridging laboratory science with clinical applications. Regenerative medicine also forms a core part of his scientific interests, particularly in osteogenesis, cartilage repair, and wound healing using advanced materials such as nanofibers and bioceramic scaffolds. Additionally, he has a strong interest in the osteogenic differentiation of stem cells, 3D-bioprinting, and the role of extracellular matrices in tissue regeneration. His research has also extended into COVID-19 vaccine safety in non-human primates, indicating his capability to contribute to both human and animal health sciences. These diverse interests align with global scientific priorities and enhance his ability to collaborate across disciplines. His work frequently merges material science, biotechnology, and cellular biology, making him an asset in cross-disciplinary research teams. Dr. Aminianfar’s vision is to continue contributing toward the development of safe and effective biomedical products, while advancing diagnostic methods that serve both veterinary and medical communities.
Research Skills
Dr. Hossein Aminianfar possesses a versatile and robust set of research skills that underpin his scientific contributions across various domains. His core technical competencies include histopathological evaluation, immunohistochemistry, and molecular diagnostics, which he uses to investigate complex pathological conditions in animals. He is adept in stem cell culturing, scaffold fabrication, and in vitro/in vivo models, particularly those related to bone and cartilage regeneration. His expertise in designing and conducting animal model studies for drug safety and potency assessments is highly valued in pre-clinical research environments. Dr. Aminianfar also demonstrates significant capability in scientific writing, data analysis, and interdisciplinary collaboration, as reflected in his co-authorship of more than 20 peer-reviewed journal articles. He is trained in laboratory animal handling and ethical research protocols, having completed certified courses in toxicologic pathology and animal experimentation. His diagnostic acumen in veterinary pathology, especially concerning ruminant abortion and equine diseases, complements his laboratory-based skills. These competencies are strengthened by his ability to translate complex experimental outcomes into practical insights and scientific innovations. Overall, Dr. Aminianfar’s research skills position him as a knowledgeable and dependable researcher capable of leading studies with both scientific rigor and clinical relevance.
Awards and Honors
Dr. Aminianfar’s career reflects a steady progression of achievements, certifications, and acknowledgments that affirm his credibility in the scientific and veterinary communities. Though he has not listed traditional awards, he has obtained multiple professional certifications from prestigious organizations. These include a certification in “Optimizing Toxicologic Pathology Data” from the Society of Toxicologic Pathology and participation in specialized courses offered by the Davis-Thompson Foundation, such as toxicologic pathology and pathology of abortion in various animals. He also completed certified training on the principles of working with laboratory animals, administered by the National Institute for Medical Research Development under Iran’s Ministry of Health and Medical Education. His academic presentations, including his dissertation showcased at the European Congress in Berlin, serve as further testimony to his scholarly recognition. Additionally, his role on the pathology committee of the Iranian Veterinary Society and his membership in multiple scientific councils demonstrate trust and leadership within his professional networks. These honors, combined with his certification track record and research-based recognitions, confirm Dr. Aminianfar’s position as an active and credible member of both national and international research communities.
Conclusion
In conclusion, Dr. Hossein Aminianfar stands out as a dynamic and impactful researcher in the field of veterinary anatomic pathology. His multidisciplinary expertise, encompassing regenerative medicine, toxicologic pathology, and translational science, uniquely positions him to contribute to both academic and clinical advancements. As an academic, entrepreneur, and diagnostician, he brings a rare combination of skills that bridge the gap between theory and practice. His extensive publication record, professional certifications, and leadership roles in various scientific bodies reinforce his status as a dedicated and accomplished researcher. While his career could further benefit from increased international collaborations, patent outputs, and grant leadership, the depth and quality of his current contributions are undeniably strong. Dr. Aminianfar’s research not only supports the development of innovative therapeutic solutions but also enhances diagnostic practices in veterinary medicine. His forward-looking approach, commitment to scientific integrity, and dedication to applied research make him a highly deserving candidate for the Best Researcher Award. As he continues to explore new scientific frontiers and mentor emerging researchers, Dr. Aminianfar is poised to make even greater contributions to global science and healthcare.
Publication Top Notes
1. A Report of Aflatoxicosis in Hand-fed Ewe Lambs Exhibiting Icterus After Hepatic Failure and Hemoglobinuria
Authors: Aminianfar, H.; Samiee, N.; Sharifzadeh, A.; Lalehpoor, M.; Safavi, S.F.; Hooyeh, M.M.
Year: 2024
2. Evaluating Osteogenic Potential of a 3D-Printed Bioceramic-Based Scaffold for Critical-sized Defect Treatment: An In Vivo and In Vitro Investigation
Authors: Safiaghdam, H.; Baniameri, S.; Aminianfar, H.; Mohajeri, S.F.; Dehghan, M.M.; Tayebi, L.; Nokhbatolfoghahaei, H.; Khojasteh, A.
Year: 2024
3. Targeted Delivery of Doxorubicin by SP5-52 Peptide Conjugated Exosome Nanoparticles into Lung Tumor: An In Vitro and In Vivo Study
Authors: Ayda; Shirangi, A.; Asadi, M.; Farokhi, M.; Gholami, M.; Aminianfar, H.; Atyabi, F.; Rassoul Dinarvand
Year: 2023
4. Characterization of Stability, Safety and Immunogenicity of the mRNA Lipid Nanoparticle Vaccine Iribovax® Against COVID-19 in Nonhuman Primates
Authors: Zamani, P.; Mashreghi, M.; Rezazade Bazaz, M.; Zargari, S.; Alizadeh, F.; Dorrigiv, M.; Abdoli, A.; Aminianfar, H.; Hatamipour, M.; Zarqi, J. et al.
Year: 2023
5. 3D‐Printed MgO Nanoparticle Loaded Polycaprolactone β‐Tricalcium Phosphate Composite Scaffold for Bone Tissue Engineering Applications: In‐Vitro and In‐Vivo Evaluation
Authors: Safiaghdam, H.; Nokhbatolfoghahaei, H.; Farzad-Mohajeri, S.; Dehghan, M.M.; Farajpour, H.; Aminianfar, H.; Bakhtiari, Z.; Jabbari Fakhr, M.; Hosseinzadeh, S.; Khojasteh, A.
Year: 2023
6. Comparison of Engineered Cartilage Based on BMSCs and Chondrocytes Seeded on PVA‐PPU Scaffold in a Sheep Model
Authors: Taghizadehjahed, M.; Sepahdar, A.; Rabiee, N.; Nazbar, A.; Farzad-Mohajeri, S.; Dehghan, M.M.; Shokrgozar, M.A.; Majidi, M.; Mardjanmehr, S.H.; Aminianfar, H. et al.
Year: 2022
7. Novel Therapeutic Approach to Slow Down the Inflammatory Cascade in Acute/Subacute Spinal Cord Injury
Authors: Hashemizadeh, S.; Hosseindoost, S.; Omidi, A.; Aminianfar, H.; Ebrahimi-Barough, S.; Ai, J.; Arjmand, B.; Hadjighassem, M.
Year: 2022
8. An Incidence of Aflatoxicosis in Hand-fed Ewe Lambs Exhibiting Icterus Subsequent to Hepatic Failure and Hemoglobinuria
Authors: Hooyeh, M.M.; Aminianfar, H.; Sharifzadeh, A.; Lalehpoor, M.; Samiee, N.
Year: 2022
9. An Integrated Microfluidic Device for Stem Cell Differentiation Based on Cell-imprinted Substrate Designed for Cartilage Regeneration in a Rabbit Model
Authors: Kashani, S.Y.; Moraveji, M.K.; Taghipoor, M.; Kowsari-Esfahan, R.; Hosseini, A.A.; Montazeri, L.; Dehghan, M.M.; Gholami, H.; Farzad-Mohajeri, S.; Mehrjoo, M. et al.
Year: 2021